Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astellas, Basilea, Biogen, Eisai, Erasca, Glaxosmithkline, Global Blood, Karyopharm, Lyell, Medicago, Medicenna, Merck & Co., Miromatrix, Obseva, Paratek, Pfizer, Seagen, Senhwa, Vir, Xalud, Zai.